当前位置:首页 > 文献互助 > 互助详情

Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial复制

用户jFEnCL9cudRQ 2小时前 8 10 已关闭

DOI:复制

文献链接:复制

其他信息:

M Saxena, L Laffin, C Borghi, BF Fernandez, JK Ghali…
JAMA, 2025
jamanetwork.com
Importance Uncontrolled hypertension remains a global health concern and dysregulated aldosterone production is a central mechanism. Lorundrostat, a novel aldosterone synthase inhibitor that reduces aldosterone production, demonstrated efficacy in participants with uncontrolled hypertension, including those with treatment-resistant hypertension. Objective To evaluate the efficacy and safety of lorundrostat for lowering blood pressure (BP) when added to a prescribed regimen of 2 to 5 antihypertensive medications in adults with …

互助时间线

2026-02-06 10:09:27 [关闭求助]

楼主用户jFEnCL9cudRQ关闭了求助

2026-02-06 10:08:14 [发起求助]

最新发布的求助